These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 16671839)

  • 1. Combined one-tube osmotic fragility (OF) test and dichlorophenol-indolphenol (DCIP) test screening for hemoglobin disorders, an experience in 213 Thai pregnant women.
    Wiwanitkit V; Suwansaksri J; Paritpokee N
    Clin Lab; 2002; 48(9-10):525-8. PubMed ID: 12389713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of osmotic fragility test and dichlorophenol indophenol precipitation test for screening of thalassemia and Hb E.
    Sangkitporn S; Sangkitporn S; Sangnoi A; Supangwiput O; Tanphaichitr VS
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1538-42. PubMed ID: 16610659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined osmotic fragility and dichlorophenol-indolphenol test for hemoglobin disorder screening in Thai pregnant subjects: an appraisal.
    Wiwanitkit V
    Lab Hematol; 2004; 10(2):119-20. PubMed ID: 15224769
    [No Abstract]   [Full Text] [Related]  

  • 4. A cost utility analysis of the right method for screening hemoglobin E among Thai pregnant women.
    Wiwanitkit V
    Arch Gynecol Obstet; 2006 May; 274(2):88-90. PubMed ID: 16496168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia.
    Fucharoen G; Sanchaisuriya K; Sae-ung N; Dangwibul S; Fucharoen S
    Bull World Health Organ; 2004 May; 82(5):364-72. PubMed ID: 15298227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using of osmotic fragility (OF) and dichlorophenol-indolephenol (DCIP) tests screening for antenatal clinic: appraisal of usefulness of the program in rural Thai communities.
    Wiwanitkit V
    Rural Remote Health; 2006; 6(2):587. PubMed ID: 16671839
    [No Abstract]   [Full Text] [Related]  

  • 7. Antenatal herpes serologic screening: an appraisal of the evidence.
    Tita AT; Grobman WA; Rouse DJ
    Obstet Gynecol; 2006 Nov; 108(5):1247-53. PubMed ID: 17077252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis.
    Zeuner D; Ades AE; Karnon J; Brown J; Dezateux C; Anionwu EN
    Health Technol Assess; 1999; 3(11):i-v, 1-186. PubMed ID: 10516927
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can prevention be marketed profitably?
    Stanaland AJ; Gelb BD
    J Health Care Mark; 1995; 15(4):59-63. PubMed ID: 10154647
    [No Abstract]   [Full Text] [Related]  

  • 11. Adult screening for anemia and hemoglobinopathies.
    Nurse Pract; 1995 Dec; 20(12):48-51. PubMed ID: 8610034
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk screening for spontaneous preterm labour.
    Khan KS; Honest H
    Best Pract Res Clin Obstet Gynaecol; 2007 Oct; 21(5):821-30. PubMed ID: 17462957
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.